FAT1 and tongue neoplasm: Importantly, the additional loss of FAT1 enhanced the antitumor activity of CPI‐613 treatment in SCC1 tumors, as evidenced by a further decrease in tongue tumor growth (Figure 4E,F) and a reduced number of Ki67‐positive cells in tumor tissues (Figure 4G).